Here’s How 106 – Twitter Wars
Last Saturday there was a demonstration outside the Dáil that was hastily organised to try to capitalise on a controversy that you may or may not have noticed, depending on what corners of Twitter you inhabit, if any. The genesis of this was an article on the website Gript, a clone of far-right A...
New Frontlines: Trends in Veterans' Suicide Prevention and Mental Health Success with Dr. Joe Geraci | Ep. 133
“We need to leverage the sea of Goodwill in the community to do more than just say ‘Thank you for your service.’ Mentor, hire, help with the transition from active duty to civilian life.” - Dr. Joe GeraciI met Dr. Joseph Geraci on the advisory committee through "Face the Fight" a consortium/initi...
E172 | The problems that modern AI methods have with patient populations in oncology and neuroscience
This powerful episode dives into one of the most urgent issues in modern healthcare; how current AI systems in clinical trials are missing the mark for diverse and underrepresented patient populations, especially in oncology and neurology.
Guest Dr. Joseph Geraci, mathematician, quantum machine l...
AI in Clinical Trials. A Scientist's Perspective.
Send us Fan Mail
Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding pati...
E191: Quantum Computation In Medicine: The Challenges, What Comes After Large Language Models For Medicine
In this episode, we explore the future of medicine beyond artificial intelligence with Joseph Geraci — mathematician, medical scientist, and quantum machine learning pioneer.
While today’s AI breakthroughs and large language models (LLMs) have transformed diagnostics, data analysis, and drug disc...
AI, machine learning and Disease. How a Polymath is pioneering the future of medicine.
Dr. Joseph Geraci shares his early fascination with numbers and mathematics, childhood experiences, mathematical synesthesia, dream revelations, and the development of Netramark and machine learning in cancer research. The conversation delves into the intricacies of language models and machine le...
Joseph Geraci, CSO/CTO & Co-Founder at NetraMark
In this episode, we sit down with Dr. Joseph Geraci — mathematical physicist, medical scientist, and AI innovator — to explore how artificial intelligence is transforming the future of medicine and clinical research.
Dr. Geraci began his career in quantum computing and mathematical physics, earni...
Enriching Clinical Trials With Machine Learning
In this episode of JAMA+ AI Conversations, Roy Perlis, MD, MSc, and Joseph Geraci, PhD, of Queen's University discuss using machine learning to analyze clinical trials and related FDA interactions. Geraci's work focuses on identifying subpopulations with different responses to help plan and analy...
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
In this episode of Beyond Compliance, Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, speaks with Joseph Geraci, PhD, co-founder and chief scientific and technical officer at NetraMark, about why explainable AI, not black-box prediction, is needed to reveal clinical...
From Quantum Physics To Precision Medicine: The AI Search For Hidden Patterns | Dr. Joseph Geraci, Ph.D. - Co-Founder, Chief Technology Officer and Chief Scientific Officer, NetraMark
Send us Fan Mail
What if a promising drug fails a clinical trial not because the drug doesn't work, but because it works for a subset of patients whose response gets lost in the averages? What if AI could help us find those patients hidden inside the data? That's the challenge we're exploring tod...
